Macular Degeneration Treatments

New CentraSight Telescope for Macular Degeneration More Available

The CentraSight Telescope for macular degeneration was approved by the FDA last year. It is now more widely available!


CentraSight Now Available, CMS to reimburse for implantable telescope to treat macular degeneration

VisionCare increases provider locations for implantation of the CentraSight telescope for macular degeneration.  The telescope, indicated for patients with end stage (advanced) macular, was FDA approved last fall for use in selected patients suffering from the blinding disease.

The device and implantation is covered by Medicare for those who meet certain criteria.  The CentraSight Treatment program includes pre-operative evaluation and diagnosis and post-operative care.

Are You a Candidate for New Telescope?

For you to be considered a candidate, general guidelines include;

  • You have permanent loss of vision from advanced (End Stage) ARMD
  • You no longer would benefit from drug treatment (e.g. anti-VEGF)
  • You have not had cataract surgery in the eye to be considered
  • You meet other criteria including age, vision and have a healthy cornea

Team Approach

Possible candidates must have an evaluation with a retina specialist to confirm the diagnosis of macular degeneration (ARMD) and to determine if alternative treatments are possible.

Candidates will have the natural lens removed and replaced with the miniature CentraSight telescope.  The procedure is very similar to the “remove and replace” sequence of cataract surgery where the natural lens is removed and replaced with an artificial implant.

After the operation, unlike cataract surgery, training is necessary to teach you how to learn and adapt with your new “vision.”  Unlike cataract surgery, usually performed in patients with a healthy retina, vision is improved, yet different.

The telescope works much like a magnifier.  The resultant image focused on the retina is enlarged, making the area damaged by ARMD relatively smaller.  There is a patient education video on CentraSight.

What Does This Mean?

Many patients have been anxiously awaiting the news.  As a provider, I am hopeful to learn more about this from both doctors and patients.  As with anything new, caution should be exercised in terms of managing your expectations.

I am most interested to see how much “learning” is required after the operation.  I would recommend viewing the CentraSight telescope as a low-vision aid.  My experience with low-vision aids and patients’ appreciation is that the patient must be motivated.

Low vision aids require work to re-learn how to perform routine tasks and I have found unmotivated patients don’t respond well.




By Randall Wong, M.D.

As a retina specialist, I've been very successful with my websites to educate my patients about what I do professionally.

I am a father of five, have a passion for SEO, love Dunkin' Donuts and don't care for Starbucks coffee, love tennis, but only like to watch golf. I'm a huge youth ice hockey supporter and love Labrador retrievers.

9 replies on “New CentraSight Telescope for Macular Degeneration More Available”

Hi Doc.
I have a diabatic retinopathy. I had laser in both eyes and a number of AVASTIN injection in both eyes. Two days ago the Doctor asked me to do a OCT test. He said the results are ok and it seems there is no edima. Are there normal range in the OCT one can note?
Best wishes to a great Doctor

my husband has lost 80%ov his sight 2yrs back n bank job is inherited dry MD.MY UNCLE who z my father in law n my brother in law are also suffering from the same.i need this telescope 4 my ov luck 2 d researchers.GOD bless u.

Leave a Reply

Your email address will not be published. Required fields are marked *

Verified by MonsterInsights